ArticleA phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia
Under a Creative Commons license
open access
Key words
Sarcopenia
aging
lean body mass
muscle
selective androgen receptor modulator
Cited by (0)
© 2013 SERDI Publisher.